Hypertension and hyperhomocysteinemia as risk factors for chronic kidney disease: A dangerous duo?
作者信息
Katsimardou Alexandra, Stavropoulos Konstantinos, Imprialos Konstantinos, Doumas Michael, Athyros Vasilios G
机构信息
2nd Propedeutic Department of Internal Medicine, Aristotle University, School of Medicine, Thessaloniki, Greece.
出版信息
J Clin Hypertens (Greenwich). 2019 Oct;21(10):1578-1579. doi: 10.1111/jch.13676. Epub 2019 Sep 16.
Abstract
摘要
相似文献
1
Hypertension and hyperhomocysteinemia as risk factors for chronic kidney disease: A dangerous duo?高血压和高同型半胱氨酸血症作为慢性肾病的危险因素：一对危险组合？
J Clin Hypertens (Greenwich). 2019 Oct;21(10):1578-1579. doi: 10.1111/jch.13676. Epub 2019 Sep 16.
2
Synergistic interaction of hypertension and hyperhomocysteinemia on chronic kidney disease: Findings from the National Health and Nutrition Examination Survey 1999-2006.高血压和高同型半胱氨酸血症对慢性肾脏病的协同作用：来自 1999-2006 年全国健康和营养调查的发现。
J Clin Hypertens (Greenwich). 2019 Oct;21(10):1567-1577. doi: 10.1111/jch.13673. Epub 2019 Sep 16.
3
Diet-induced hyperhomocysteinemia impairs vasodilation in 5/6-nephrectomized rats.饮食诱导的高同型半胱氨酸血症可损害 5/6 肾切除大鼠的血管舒张功能。
Amino Acids. 2018 Oct;50(10):1485-1494. doi: 10.1007/s00726-018-2626-3. Epub 2018 Jul 30.
4
Hyperhomocysteinemia increases the risk of chronic kidney disease in a Chinese middle-aged and elderly population-based cohort.高同型半胱氨酸血症增加了中国中老年人群队列中慢性肾脏病的发病风险。
Int Urol Nephrol. 2017 Apr;49(4):661-667. doi: 10.1007/s11255-016-1452-3. Epub 2016 Nov 7.
5
High Prevalence of Hyperhomocysteinemia and Its Association with Target Organ Damage in Chinese Patients with Chronic Kidney Disease.中国慢性肾脏病患者高同型半胱氨酸血症的高患病率及其与靶器官损害的关系
Nutrients. 2016 Oct 20;8(10):645. doi: 10.3390/nu8100645.
6
7
Hyperhomocysteinemia in menopausal hypertension: an added risk factor and a dangerous association for organ damage.绝经后高血压中的高同型半胱氨酸血症：一个额外的危险因素以及器官损伤的危险关联。
Eur Rev Med Pharmacol Sci. 2002 Jul-Aug;6(4):81-7.
8
Uricemia and homocysteinemia: nontraditional risk factors in the early stages of chronic kidney disease--preliminary data.尿酸血症和高同型半胱氨酸血症：慢性肾脏病早期的非传统风险因素——初步数据
Eur Rev Med Pharmacol Sci. 2014;18(7):1010-7.
9
Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II: Role in disease conditions: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and the Japanese Society of Hypertension.内皮细胞因子在慢性肾脏病发病机制和治疗中的作用 第二部分：疾病状态中的作用：欧洲高血压学会内皮素和内皮细胞因子工作组与日本高血压学会的联合共识声明。
J Hypertens. 2018 Mar;36(3):462-471. doi: 10.1097/HJH.0000000000001600.
10
Contribution of non-traditional lipid profiles to reduced glomerular filtration rate in H-type hypertension population of rural China.中国农村 H 型高血压人群中非传统脂质谱对肾小球滤过率降低的贡献。
Ann Med. 2018 May;50(3):249-259. doi: 10.1080/07853890.2018.1445277. Epub 2018 Feb 28.
引用本文的文献
1
Vitamin B12, folate, and homocysteine in metabolic syndrome: a systematic review and meta-analysis.代谢综合征中的维生素 B12、叶酸和同型半胱氨酸：系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2023 Sep 13;14:1221259. doi: 10.3389/fendo.2023.1221259. eCollection 2023.
2
Hyperhomocysteinemia exacerbates acute kidney injury increased mitochondrial damage.高同型半胱氨酸血症会加剧急性肾损伤并增加线粒体损伤。
Front Physiol. 2022 Oct 5;13:967104. doi: 10.3389/fphys.2022.967104. eCollection 2022.
本文引用的文献
1
Synergistic interaction of hypertension and hyperhomocysteinemia on chronic kidney disease: Findings from the National Health and Nutrition Examination Survey 1999-2006.高血压和高同型半胱氨酸血症对慢性肾脏病的协同作用：来自 1999-2006 年全国健康和营养调查的发现。
J Clin Hypertens (Greenwich). 2019 Oct;21(10):1567-1577. doi: 10.1111/jch.13673. Epub 2019 Sep 16.
2
Folic Acid and Homocysteine in Chronic Kidney Disease and Cardiovascular Disease Progression: Which Comes First?慢性肾脏病与心血管疾病进展中的叶酸和同型半胱氨酸：何者为先？
Cardiorenal Med. 2017 Oct;7(4):255-266. doi: 10.1159/000471813. Epub 2017 Jun 21.
3
Chronic Kidney Disease.慢性肾脏病。
Lancet. 2017 Mar 25;389(10075):1238-1252. doi: 10.1016/S0140-6736(16)32064-5. Epub 2016 Nov 23.
4
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants.1975年至2015年全球血压趋势：对1479项基于人群的测量研究（涉及1910万参与者）的汇总分析。
Lancet. 2017 Jan 7;389(10064):37-55. doi: 10.1016/S0140-6736(16)31919-5. Epub 2016 Nov 16.
5
Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial.叶酸治疗对慢性肾脏病进展的疗效：中国脑卒中一级预防试验的肾脏子研究。
JAMA Intern Med. 2016 Oct 1;176(10):1443-1450. doi: 10.1001/jamainternmed.2016.4687.
6
Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.慢性肾脏病中的隐匿性高血压和夜间血压升高：患病率及其与靶器官损害的关联
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):642-52. doi: 10.2215/CJN.08530815. Epub 2016 Feb 18.
7
CKD Prevalence Varies across the European General Population.慢性肾脏病（CKD）在欧洲普通人群中的患病率各不相同。
J Am Soc Nephrol. 2016 Jul;27(7):2135-47. doi: 10.1681/ASN.2015050542. Epub 2015 Dec 23.
8
The double challenge of resistant hypertension and chronic kidney disease.耐药性高血压和慢性肾病的双重挑战。
Lancet. 2015 Oct 17;386(10003):1588-98. doi: 10.1016/S0140-6736(15)00418-3.
9
A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010.2010年全球慢性肾脏病负担的全球人群数据的系统分析。
Kidney Int. 2015 Nov;88(5):950-7. doi: 10.1038/ki.2015.230. Epub 2015 Jul 29.
10
Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries.高、中、低收入国家城乡社区高血压的患病率、知晓率、治疗率和控制率。
JAMA. 2013 Sep 4;310(9):959-68. doi: 10.1001/jama.2013.184182.
Zotero 插件